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Abstract
Sindbis virus (SIN) expression vectors offer the opportunity for studying neuropathogenesis because of their distinct neural cell tropism.
Here, we demonstrate that a recombinant SIN vector expressing EGFP (SINrep5-EGFP) infected multiple cell types including neural cells
from several species relevant to lentivirus pathogenesis with high levels of transgene expression. Infection of human neurons by a
recombinant SIN (SINrep5-JRFL) expressing the full-length envelope from a neurovirulent human immunodeficiency virus type 1 (HIV-1)
strain (JRFL) caused increased cytotoxicity compared to infection with SINrep5-EGFP (P  0.001), while no cytotoxicity was observed
among infected human astrocytes or monocytoid cells. Both human monocyte-derived macrophages (MDM) (P  0.01) and astrocytes (P
 0.001) infected with SINrep5-JRFL released soluble neurotoxins in contrast to SINrep5-EGFP or mock-infected cells, although this was
most prominent for the astrocytes. Implantation of SINrep5-JRFL into the brains of SCID/NOD mice induced neuroinflammation, neuronal
loss, and neurobehavioral changes characteristic of HIV-1 infection, which were not present in SINrep5-EGFP or mock-infected animals.
Thus SIN expression vectors represent novel tools for studying in vitro and in vivo HIV-1 neuropathogenesis because of their high levels
of transgene expression in specific cell types within the brain.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Sindbis virus (SIN) is a prototypic member of the alpha-
virus family with a positive-strand RNA genome containing
two open reading frames (ORF). The 5 ORF encodes the
viral replicase (the nonstructural proteins), which catalyzes
genome replication and transcription, while the 3 ORF
encodes the structural proteins necessary for virus particle
formation, which are translated from a subgenomic (sg)
mRNA (reviewed in Strauss and Strauss, 1994). SIN to-
gether with the alphaviruses Semliki Forest virus (SFV) and
Venezuelan equine encephalitis (VEE) virus have received
increasing attention for their use as vectors for heterologous
gene expression in molecular and cell biology studies
(Schlesinger, 2000). More recently, there has been increas-
ing interest in alphavirus vectors for use as therapeutic
agents, especially for developing vaccines (Gardner et al.,
2000; Schlesinger and Dubensky, 1999). Alphavirus vectors
are appealing because of their wide host range and biolog-
ical safety in humans (Strauss and Strauss, 1994). In many
alphavirus vector systems, the structural proteins genes are
replaced by a transgene of interest (Frolov et al., 1996;
Schlesinger, 2000), permitting the viral replicase to repli-
cate the genomic vector RNA and express the heterologous
gene via the sg mRNA in the transfected cell. The self-
replicating alphavirus vector containing a transgene of in-
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terest is packaged into a virus particle by addition of a
defective helper virus construct, which supplies the requi-
site structural proteins (Frolov et al., 1996; Schlesinger,
2000).
The neurotropism of SIN is an attractive property for
studying different aspects of central nervous system (CNS)
function and disease. SIN vectors have been successfully
exploited, expressing heterologous genes in brains of rats
and mice (Altman-Hamamdzic et al., 1997; D’Apuzzo et al.,
2001; Gwag et al., 1998), and are promising therapeutic
tools (Lundstrom, 1999). SIN infection and replication may
result in apoptotic death of the infected cell (Griffin and
Hardwick, 1997). However, SIN vectors with reduced cy-
totoxicity and reduced replicative capacity in vitro have
been developed and the extent of their cytotoxic effects
depends on the cell type infected (Agapov et al., 1998;
Dryga et al., 1997; Frolov et al., 1999). Limited data are
available regarding the cytopathogenic effects of SIN vec-
tors on neuronal cells in vitro and in vivo in the CNS. In this
article we investigated the cytotoxicity of a SIN expression
vector in vitro and in vivo and its potential for studying
human immunodeficiency virus type 1 (HIV-1) neuropatho-
genesis.
Approximately 20% of untreated AIDS-defined patients
will develop HIV-associated dementia (HAD) (McArthur et
al., 1993), but the mechanisms underlying this neurological
disorder remain uncertain. Infection by HIV-1 causes in-
flammation within the brain and neuronal degeneration,
resulting in HAD (Power and Johnson, 2001). Both viral
and host gene expression have been implicated in the patho-
genesis of HAD (Chen et al., 1997; Corder et al., 1998;
Power et al., 1998; Quasney et al., 2001; van Rij et al.,
1999). Infection of the brain by HIV-1 and subsequent
production of viral proteins in the brain are considered to
play an important role in the neuropathogenesis of HIV-1
(reviewed in Kaul et al., 2001; Mollace et al., 2001; Power
and Johnson, 2001). The HIV-1 envelope and Tat proteins
are known to initiate several different cell-signaling path-
ways that lead to the production of different proinflamma-
tory molecules. These molecules trigger other pathways that
elicit the production of cytokines, matrix metalloprotein-
ases, free radicals, and other unknown molecules with pu-
tative neurotoxic actions, ultimately resulting in neuronal
degeneration or death. A SIN expression vector containing
an HIV-1 gene offers the possibility of studying HIV-1
neuropathogenesis in a manner that resembles an infection,
independent of other HIV-1 genes in vitro and in vivo as
well as focusing on specific cell types and relevant regions
of the brain. In addition, it allows the study of HIV-1
neuropathogenesis in hosts normally not susceptible to
HIV-1 infection, such as mice and rats (Hofmann et al.,
1999; Keppler et al., 2001; Lewis and Johnson, 1995; Mari-
ani et al., 2000; Morrow et al., 1987; Wei et al., 1998).
Herein we demonstrate that a recombinant SIN vector was
able to infect several neural cell types relevant to HIV-1
neuropathogenesis, in both mouse and human primary cul-
tures. Cytotoxicity of the SIN vector expressing enhanced
green fluorescent protein (EGFP) was minimal in vitro and
in vivo. Conversely, the same vector expressing the enve-
lope protein of a brain-derived HIV-1 strain from a patient
with HAD was neurotoxic in vitro and induced a neuroin-
flammatory response as well as neuronal injury in mice. Our
findings indicate that SIN vectors can be used to express
HIV-1 envelope protein in the brain and provide insight into
the mechanisms underlying HIV-1 related neuropathogen-
esis.
Results
Tropism of SINrep5-EGFP in cell lines and primary
cultures
Although alphavirus vectors have been shown to infect
cells from different species in vitro (Lundstrom, 1999;
Wahlfors et al., 2000), the extent of infection of cells from
different species and lineages by SIN, especially those rel-
evant to neuropathogenesis studies, required further inves-
tigation. To assess the ability of the SINrep5 vector system
(Bredenbeek et al., 1993) to infect cells relevant for the
study of HIV-1 neuropathogenesis, the ORF encoding the
EGFP was inserted as a reporter gene into the SINrep5
vector, resulting in SINrep5-EGFP. Thus, the tropism of the
recombinant SINrep5-EGFP virus in vitro was determined
using immortalized cell lines and primary cell cultures (Ta-
ble 1). As BHK-21 cells are highly susceptible to SIN
infection, infection efficiency was determined relative to the
number of infected BHK-21 cells using the same viral input
titer and the same number of cells. SINrep5-EGFP infected
neuronal and nonneuronal cell lines from mouse, rat, cat,
and human, with differing infection efficiencies (Table 1).
SINrep5-EGFP infected the human nonneuronal cell line
293T and the mouse neuroprogenitor cell line C17.2,
with efficiencies of 48 and 22%, respectively. The Crandle
feline kidney (CrFK) cells were infected with an efficiency
of 7.6% relative to BHK-21 cells. All other cell lines de-
rived from either mouse or human were infected with much
lower efficiency compared to BHK-21 cells (1% or less).
The human immortalized cell lines infected by SINrep5-
EGFP included a cholinergic neuronal cell line (LAN-2),
astrocytic cells (U373), and primary monocyte-derived
macrophages (MDM) (Table 1, Fig. 1C). In all infected
cells, the level of EGFP expression was high and easily
detectable, which confirmed that the SINrep5-EGFP vector
expressed efficiently in cells of different species, including
humans.
As we were specifically interested in using SINrep5 for
transgene expression in neural cells, the ability to infect
cells in different primary CNS-derived cultures was deter-
mined with infection efficiency estimated relative to
BHK-21 cells. SINrep5-EGFP readily infected neurons in
primary cultures of fetal neurons from mouse, rat, and
62 G. van Marle et al. / Virology 309 (2003) 61–74
human (Fig. 1 and Table 1), and infection of organotypic rat
hippocampal tissue slices showed high levels of EGFP ex-
pression in pyramidal neurons in the CA1 and CA3 region
(Fig. 1A). The results obtained with the organotypic hip-
pocampal tissue slices corresponded with previous reports
(Ehrengruber et al., 1999), although we observed that by
adding virus to the media instead of direct injection into the
tissue, selective infection of neurons occurred without glial
infection (Fig. 1A). The interest in clinical and experimental
applications of neural stem cells (Bjorklund and Lindvall,
2000) prompted us to assess their susceptibility to SIN
infection. As shown in Fig. 1B and Table 1, both fetal and
adult neural stem cells could be infected with SINrep5-
EGFP and high levels of EGFP expression were observed.
In addition, formation of cellular processes by the stem cells
was also observed (Fig. 1B). In all primary cultures and rat
hippocampal tissue slices, high levels of EGFP expression
were observed without any obvious changes in cell mor-
phology or loss of cells, 3–5 days after infection. Mixed
cultures of human astrocytes and microglia were also suc-
cessfully infected by SINrep5-EGFP, which was confirmed
by immunostaining with antibodies directed against GFAP
and CD14 (markers for astrocytes and microglia, respec-
tively) (Fig. 1E–F). In contrast mouse and human oligoden-
drocytes in mixed cultures could not be infected by SIN-
rep5-EGFP, which was confirmed by immunostaining with
the H8H9 antibody directed against myelin basic protein
(MBP) (data not shown). These results reflected the reported
tropism of SIN in mice (Strauss and Strauss, 1994), but also
extended earlier findings by demonstrating that SIN can also
infect primary cells derived from the human CNS.
Infectivity and expression of HIV-1 envelope by SINrep5-
JRFL
To explore the possibility of using a SIN expression
vector as a tool to study HIV-1 neuropathogenesis, SIN-
rep5-JRFL expressing the envelope protein of HIV-1 strain
JRFL was constructed. JRFL is an HIV-1 strain derived
from the brain of a patient with HAD (Li et al., 1991), and
the envelope has potent neurotoxic actions (Power et al.,
1998). Fig. 2A shows the expression of the HIV-1 JRFL
envelope in the neural cell line NG108 infected with SIN-
rep5-JRFL. Similar results were obtained for U373 cells
infected with SINrep5-JRFL, and also in BHK-21, LAN-2,
and 293T cells, in which JRFL envelope expression was
readily detectable (data not shown). In addition, JRFL en-
velope is correctly processed and the surface unit (SU)
gp120 released into the culture media of cells infected or
transfected with SINrep5-JRFL, as illustrated by immuno-
detection of HIV-1 gp120 in culture media from BHK cells
transfected with SINrep5-JRFL (Fig. 2B).
Cytotoxicity of SINrep5-EGFP and SINrep5-JRFL in vitro
In addition to susceptibility, relative EGFP expression
levels were determined in the U373 (astrocytic), NG108
(neuronal), and BHK-21 cell lines, following infection us-
ing matched multiplicities of infection (m.o.i.) at which
equal numbers of cells were infected for each cell line. The
relative amounts of EGFP fluorescence measured (Fig. 3A),
revealed that the U373 and NG108 cells infected with SIN-
rep5-EGFP expressed significantly more EGFP compared to
the infected BHK-21 cells (P  0.05). This indicated that
SINrep5 transgene expression was greater in the cells of
neural origin using matched m.o.i.
To examine the intrinsic cytotoxicity of the SINrep5
vector in vitro, NG108, LAN-2, and U373 cells were in-
fected with SINrep5-EGFP, because they closely resemble
the cells infected or affected by in vivo HIV-1 infection and
are infected with equal efficiency by the recombinant SIN
vector. The levels of cell death among each cell line induced
by infection with SINrep5-EGFP were minimal and similar
to controls (Fig. 3B–D). To investigate the effect of expres-
sion of the HIV-1 JRFL envelope protein by SINrep5 on
cell death in vitro, the cytotoxicity of SINrep5-JRFL in
NG108, U373, and LAN-2 cells was also determined (Fig.
3B–D). The percentage of cell death after 24 or 48 h of
infection revealed no significant difference in cytotoxicity
of SINrep5-JRFL compared with mock or SINrep5-EGFP
infections for the U373 cells. However, the cytotoxicity of
the SINrep5-JRFL virus was significantly higher for NG108
Table 1
Tropism of SINrep5-EGFP for different cell lines and cell types
Cell type Origin/description Susceptibility to
SINrep5-EGFP
infectiona
BHK-21 Baby hamster kidney 100%
C17.2 Mouse neuroprogenitor 22%
NG108 Mouse neuroblastoma 0.6%
CrFK Crandle feline kidney 7.6%
Hela Human cervical
carcinoma
1.1%
293T Human embryonic
kidney epithilia
48%
U373 Human astrocytes 0.6%
Lan-2 Human cholinergic
neurons
0.6%
Macrophages Human monocyte
derived macrophages
0.25%
Fetal neural stem cells Mouse, primary culture 
Adult neural stem cells Mouse, primary culture 0.81%
Fetal neurons Human, primary culture 
Embryonic striatal
neurons
Rat, primary culture 
Oligodendrocytes Mouse, primary culture 
Oligodendrocytes Human, primary culture 
Microglia Human, primary culture 
Astrocytes Human, primary culture 
Hippocampal slice Rat, organotypic culture 
a Percentage of infected cells relative to number of infected BHK-21
cells using the same titer of SINrep5-EGFP. For primary cultures,   no
infection detected,   1–10%,   10–25%,   25–50%,
  50%.
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cells than for mock infection (P  0.05) and increased after
48 h. Although mock infection for 48 h increased the per-
centage of dead cells compared to regular culture media, a
significantly higher percentage of cell death was observed
for infection of the human neuronal cell line LAN-2 with
SINrep5-JRFL compared to SINrep5-EGFP and mock in-
fection after 24 and 48 h (P  0.001) (Fig. 3D). These
results indicate that HIV-1 JRFL envelope expressed by
SIN was cytotoxic in neuronal but not astrocytic cell lines.
Infection by HIV-1 results in activation of macrophages
and astrocytes resulting in the release of soluble molecules
with neurotoxic actions (Gonzalez-Scarano and Baltuch,
1999; Kaul et al., 2001). Similar to other lentiviruses in-
cluding SIV and FIV, the release of neurotoxic molecules
Fig. 1. EGFP expression in cells and rat hippocampal tissue slices infected with SINrep5-EGFP. (A) High levels of EGFP expression could be detected in
pyramidal neurons of the CA1 region of hippocampal slices. (B) Mouse adult neuronal stem cells infected with SINrep5-EGFP expressed high levels of EGFP
and were able to form cellular processes. SINrep5-EGFP also infected human MDM (C), primary human fetal neurons (D), and primary human astrocytes
(E and F). The latter was determined by detection of EGFP fluorescence (E) in combination with immunostaining for the astrocyte marker GFAP (F), in mixed
primary astrocyte cultures. (Original magnification 400).
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by HIV-1 is in part mediated by the envelope protein
(Johnston et al., 2002; Kaul and Lipton, 1999; Power et al.,
1998). To determine if infection of macrophages and astro-
cytes by SINrep5-JRFL resulted in the release of soluble
neurotoxins, human primary MDM and astrocytes were
mock infected or infected with each SINrep5 vector. Infec-
tion of both MDM and astrocytes with SINrep5-JRFL or
SINrep5-EGFP did not cause an increase in cell death for
both cell types as determined by trypan blue exclusion after
24 h (data not shown). Incubation of LAN-2 cells for 24 and
48 h with conditioned media from MDM infected with
SINrep5-JRFL resulted in an increase (P  0.01) in neuro-
nal death compared to incubation with conditioned media
derived from SINrep5-EGFP and mock-infected MDMs
(Fig. 4A). Although the cytotoxicity of conditioned media
derived from MDM was limited compared to direct infec-
tion of LAN-2 cells with SINrep5-JRFL, these results indi-
cated that SINrep5-JRFL also was able to induce indirect
neurotoxic effects, similar to earlier reports of HIV-1 infec-
tion of MDMs (Power et al., 1998). More striking were the
observations using the conditioned media from the human
primary astrocytes (Fig. 4B) infected by SINrep5-JRFL,
which induced extensive neuronal death that was not ob-
served for SINrep5-EGFP or mock-infected astrocytes (P
0.001). Indeed, incubation for 48 h with the conditioned
media from SINrep5-JRFL-infected astrocytes resulted in
100% cell death, which again was not observed for the
mock- or SINrep5-EGFP-infected astrocyte-derived condi-
tioned media. Analysis of the conditioned media derived
from the astrocytes and MDM by Western blot using the
B13 antibody revealed that no detectable HIV-1 JRFL en-
velope was released from infected cells (Fig. 4C), in con-
trast to BHK cells infected by the same virus (Fig. 2B).
As stimulated astrocytes can release glutamate and glu-
tamate receptors have been postulated to play a role in
HIV-1-induced neuronal death (Bezzi et al., 2001; Kaul et
al., 2001), the neurotoxicity of conditioned media from
astrocytes was assessed in the presence of different concen-
trations of N-methyl-D-aspartate (NMDA; MK801) and
amino-3-hydroxy-5-methyl-4-isoazole propionate (AMPA;
NBQX) receptor antagonist (Fig. 4D). No reduction in neu-
rotoxicity of conditioned media from SINrep5-JRFL-in-
fected astrocytes was observed, indicating that the neuro-
toxins produced by HIV-1 envelope in astrocytes did not
mediate neuronal death through the glutamate receptors.
Neurovirulence of SINrep5-EGFP and SINrep5-JRFL in
vivo
Since a robust difference in cytotoxicity was observed
between SINrep5-EGFP and SINrep5-JRFL in neuronal cell
lines NG108 and LAN-2, the effects of both recombinant
viruses were determined in vivo by stereotaxic implantation
into the striatum of SCID/NOD mice. This brain region was
selected because it is highly vulnerable to the effects of HIV
infection (Glass et al., 1995). High levels of EGFP expres-
sion could be detected in brain tissue primarily along the
needle track leading into the striatum by confocal fluores-
cent microscopy, at 1, 4, and 7 days after implantation with
SINrep5-EGFP (Fig. 5B and C), but not in control animals
(Fig. 5A). EGFP expressing could be easily detected for up
to 10 days after implantation, which corresponds to previ-
ous reports (Altman-Hamamdzic et al., 1997). The cells
infected by SINrep5-EGFP after striatal implantation were
primarily neurons. Immunostaining of brain sections with
an antibody directed against EGFP confirmed this observa-
tion (data not shown). Following infection with SINrep5-
JRFL, HIV-1 envelope could be detected at the injection site
at 7 days after infection using a monoclonal antibody di-
rected against HIV-1 envelope (Fig. 5D). To determine the
identity of the HIV-1 envelope-positive cells, tissue sections
were double labeled using the antibodies against ionized
calcium-binding adaptor molecule 1 (Iba-1) or glial fibril-
lary acidic protein (GFAP) and the HIV-1 envelope anti-
body followed by confocal microscopy (Fig. 5E and F).
This revealed that the HIV-1 envelope immunopositive cells
surrounding the injection site were Iba-1 positive, indicating
they were of microglial lineage. No colocalization of GFAP
and HIV-1 envelope immunoreactivity was observed. In
addition, the rotational behavior of the mice was also ana-
lyzed 3 and 7 days after striatal implantation to determine
the cytotoxic effects of the virus and delivery method (Un-
Fig. 2. HIV-1 envelop expression by SINrep5-JRFL. (A) NG108 cells infected with SINrep5-JRFL. HIV-1 envelope expressing cells are indicated with
arrows, while immunonegative cells are indicated with arrowheads. (B) Western blot analysis of immunoprecipitation of the HIV-1 strain envelope protein
from culture media from BHK cells transfected with SINrep5-JRFL, SINrep5-EGFP, and mock-transfected cells (mock), illustrating that the envelope
expressed by SIN is correctly processed and the surface unit gp120 is released into the culture media.
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gerstedt and Arbuthnott, 1970). The total mean number of
rotations (SEM) of the animals implanted with SINrep5-
JRFL was significantly lower (P  0.05, Mann-Whitney U
test) at day 7, but not day 3, compared to the SINrep5-
EGFP-implanted animals (67  5 and 119  11 rota-
tions/10 min, respectively), which did not differ from con-
trol animals, indicating that neurological injury was caused
by implantation of SINrep5-JRFL but not SINrep5-EGFP.
To determine if this neurobehavioral deficit was corre-
lated with neuropathological changes, analysis of frozen
brain sections immunostained with antibodies directed
against Iba-1 and GFAP revealed minimal activation of
microglia and astrocytes, respectively, surrounding the in-
jection site in control (Fig. 6A and D) and SINrep5-EGFP
(Fig. 6B and E)-implanted animals. However, the number of
both Iba-1 and GFAP immunopositive cells and the inten-
sity of staining were markedly increased in the animals
implanted with SINrep5-JRFL (Fig. 6C and F) compared to
SINrep5-EGFP and control animals. Moreover, neuronal
loss was also observed at the site of injection and away from
the needle track in the animals implanted with SINrep5-
JRFL after immunostaining for the neuronal nuclear protein
(NeuN) (Fig. 6I) and cresyl violet staining (data not shown),
which was not apparent in the control animals or animals
implanted with SINrep5-EGFP (Fig. 6G and H). These
findings suggested that the neuronal damage caused by
Fig. 3. Expression levels of SINrep5 in BHK-21, NG108, and U373 cells as determined by measuring EGFP fluorescence (A). NG108 and U373 cells
displayed significantly more EGFP fluorescence (i.e., EGFP expression) compared to BHK-21 cells. (* P 0.05 Dunn’s multiple comparison test). Induction
of cell death on U373 (B), NG108 (C), and LAN-2 cells (D) by SINrep5-EGFP and SINrep5-JRFL. Cells were infected at several M.O.I. for 24 and 48 h,
and cell death was assessed by trypan blue exclusion 24 and 48 h after infection. Cell death induced by media from mock-transfected BHK cells (mock) mixed
in various ratios with culture media (ranging from 3/4 to 1/4) as well as culture media alone on the different cell lines were used as controls. Cell death was
significantly increased in the neuronal cell lines LAN-2 and NG108 infected with SINrep5-JRFL compared to uninfected (mock and AIM-V) and
SINrep5-EGFP-infected cells (***P  0.001, Dunn’s multiple comparison test).
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SINrep5-JRFL led to the neurobehavioral abnormalities ob-
served in this group of animals. Overall, these results re-
vealed that SINrep5-JRFL induced more neuropathogenic
effects upon implantation into the striatum of mice com-
pared to SINrep5-EGFP.
Discussion
In this report we demonstrate that a recombinant SIN is
able to infect and efficiently express EGFP in human pri-
mary neural cells and cell lines relevant to HIV-1 patho-
Fig. 4. Neurotoxicity in LAN-2 cells of conditioned media from human MDM (A) and primary human astrocytes (B) infected with SINrep5-EGFP,
SINrep5-JRFL, or uninfected (mock). Cells were incubated for 24 and 48 h with conditioned media from astrocytes and cell death was assessed by Trypan
blue exclusion. Cell death was significantly increased in LAN-2 cells upon incubation with conditioned media of primary human astrocytes infected with
SINrep5-JRFL at both time points compared to mock and SINrep5-EGFP, while only a modest increase was observed for the MDM conditioned media (**P
 0.01, ***P  0.001, Dunn’s multiple comparison test). (C) Western blot analysis of media of mock-, SINrep5-EGFP-, and SINrep5-JRFP-infected
astrocytes (A) and MDM (M). No detectable levels of HIV-1 JRFL envelope (gp120) were observed in both astrocyte- and MDM-conditioned media.
HIV-1-infected 293T cells were used as positive control (HIV env gp120). (D) Neurotoxicity in LAN-2 cells after 24 h treatment with conditioned media
from primary human astrocytes infected with SINrep5-EGFP and SINrep5-JRFL in the presence or absence of the AMPA (NBQX) and NMDA (MK801)
receptor antagonists. Media from astrocytes infected with SINrep5-JRFL induced significantly more cell death compared to the background level of cell death
induced by conditioned media of astrocytes infected with SINrep5-EGFP (***P  0.001, Dunns multiple comparison test) and no reduction of cell death
was observed in the presence of NBQX or MK801.
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genesis without apparent cytotoxicity. Conversely, infection
by a recombinant SIN expressing the envelope derived from
a neurovirulent HIV-1 strain resulted in increased neuronal
death in vitro. Moreover, HIV-1 envelope expression in
astrocytes induced significant indirect neurotoxicity. Im-
plantation of this recombinant virus into the brain of mice
induced a marked inflammatory response and neuronal loss,
together with neurobehavioral abnormalities. These findings
indicate that the HIV-1 envelope expressed by SIN vectors
retains its neurotoxic properties both in vitro and in vivo,
and illustrate the potential of SIN expression vectors for
studying the neuropathogenesis of individual viral genes.
As it was essential to gain more insight into the cell
tropism of SIN, we tested the ability of SINrep5-EGFP to
infect neuronal and nonneuronal cells of mouse, rat, feline,
and human origin. The present studies extended earlier
studies (Lundstrom, 1999; Strauss and Strauss, 1994; Wahl-
fors et al., 2000) by showing that several primary neural cell
types of different species could be infected. In addition, the
ability of the SINrep5-EGFP virus to infect mouse fetal and
adult neural stem cells suggests SIN vectors could also be
exploited to express genes that have investigative and ther-
apeutic value in stem cell studies (Bjorklund and Lindvall,
2000). Of special interest was the ability of SINrep5-EGFP
to infect the human neuronal cell line LAN-2, the astrocytic
cell line U373, and human MDM, which was complemented
by the infection of human primary cultures showing a sim-
ilar tropism for microglia (the brain resident cells from
monocyte/macrophage lineage), astrocytes, and neurons.
The later findings indicate that in vitro SIN infects the same
cell types in primary human-derived neuronal cultures as in
mice. Astrocytes and macrophages are considered to play a
major role in the pathogenesis of many brain diseases in-
cluding HAD (Kaul et al., 2001; Kaul and Lipton, 1999;
Nath et al., 1999; Thompson et al., 2001). Cells of mono-
cyte/macrophage lineage have been proposed to act as the
vehicles by which HIV-1 may cross the blood brain barrier
(BBB) and infect the brain (Strelow et al., 2001). Moreover,
infection by HIV-1 of astrocytes and cells of macrophage/
microglial lineage within the brain results in the release of
soluble viral and host molecules with neurotoxic effects
(Kaul et al., 2001; Mollace et al., 2001; Power and Johnson,
2001). Neurons in the brain are also infected by HIV-1,
albeit at much lower levels (Bagasra et al., 1996; Nuovo et
al., 1994; Torres-Munoz et al., 2001; Trillo-Pazos et al.,
2002).
To explore the possibility of utilizing SIN vectors in the
study of HIV-1 neuropathogenesis, SINrep5-JRFL was con-
structed because the HIV-1 envelope is considered to be a
principal viral gene influencing neuronal injury and death in
HAD (Kaul et al., 2001; Power and Johnson, 2001). Given
that SINrep5-EGFP caused negligible cell death in all three
cell lines even at m.o.i.’s 50 times higher than SINrep5-
JRFL, the increased cell death in the neuronal cell lines
NG108 and LAN-2 upon SINrep5-JRFL infection was the
result of the expression of the JRFL envelope. In addition to
its direct neurotoxic effects, SINrep5-JRFL also induced
production of neurotoxic molecules by primary astrocytes
and to a much lesser extent in MDM. The high level of
neurotoxicity of the conditioned media from the primary
astrocytes suggests that astrocytes may also be an important
source of soluble neurotoxins induced by HIV-1 envelope
expression. As no detectable HIV-1 gp120 was present in
the conditioned media from SINrep5-JRFL-infected MDM
and primary astrocytes, other molecules released as a re-
sponse to expression of the HIV-1 envelope must be respon-
sible for the increased cytotoxicity of the astrocyte-condi-
tioned media. Moreover, the inability to block the
neurotoxic effects of the conditioned media derived from
the primary astrocytes infected by SINrep5-JRFL with an-
tagonists for the NMDA and AMPA receptors indicated that
these neurotoxins do not act via the glutamate receptors, in
Fig. 5. In vivo detection of EGFP and HIV-1 envelope expression detected
by confocal microscopy. EGFP was detected in neurons of the striatum of
SCID/NOD mice 7 days after implantation of SINrep5-EGFP (B and C),
while no fluorescence was observed in control animals (A). HIV-1 JRFL
envelope could be detected (indicated with arrowheads) by immunofluo-
rescence, 7 days after implantation of SINrep5-JRFL (D). Double immu-
nolabeling for HIV-1 envelope (red) and the activated microglial marker
Iba-1 (green) (E) and GFAP (green) (F) in SINrep-JRFL implanted, re-
vealed colocalization (in yellow) of the envelope protein with the micro-
glial marker Iba-1, but not with the astrocyte marker GFAP in the SINrep5-
JRFL-implanted animals (HIV-1 envelope-positive cells indicated with
arrow in E and F). (Original magnification as indicated).
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contrast to earlier studies of astrocyte-mediated neurotoxic-
ity (Araque et al., 1998; Parpura et al., 1994). However,
altered intracellular expression of viral envelope has been
previously associated with neurovirulence (Kamps et al.,
1991; Lynch et al., 1995; Lynch and Sharpe, 2000), possibly
through misfolding of the protein in the endoplasmatic re-
ticulum, which results in a stress response by the cell. The
stress response may lead to the release of potentially neu-
rotoxic molecules, including cytokines and reactive oxygen
species (Wesselingh and Thompson, 2001). The mechanism
underlying the astrocyte-mediated neurotoxicity is currently
under further investigation.
The lack of T lymphocytes in SCID/NOD mice permits
the use of these animals as model for HIV-1 neuropatho-
genesis by implanting recombinant HIV-1 proteins and hu-
man cells infected with HIV-1 or expressing specific HIV-1
proteins (Johnston et al., 2001; Persidsky et al., 1996; Tyor
et al., 1993). The robust innate inflammatory response
caused by SINrep5-JRFL consisting of microglial and as-
trocyte activation are hallmarks of HAD (Power and John-
son, 2001), indicating the SINrep5-JRFL-implanted SCID/
NOD displayed the typical features of HIV-1 infection in
terms of site of injury (the striatum) and pathological
changes. The lower total rotary behavior observed for the
Fig. 6. Neuropathological findings in brain of SCID/NOD mice following control stereotactic implantation (A, D, and G) or implantation with SINrep5-EGFP
(B, E, and H) and SINrep5-JRFL (C, F, and I). Expression of cell markers for inflammation and activation of microglia (Iba-1) (A, B, and C), astrocytes
(GFAP) (D, E, and F), and neuronal nuclei marker (NeuN) (G, H, and I), in striatal sections 7 days after implantation. Immunopositive microglia are indicated
with arrowheads and astrocytes with arrows. An increased inflammatory response with a loss in the number of neurons in the vicinity of the needletrack (T)
and surrounding tissue was observed in animals implanted with SINrep5-JRFL that was not present in control animals or animals implanted with
SINrep5-EGFP. (Original magnification 200).
69G. van Marle et al. / Virology 309 (2003) 61–74
SINrep5-JRFL-implanted animals was indicative of motor
abnormalities resulting from the neurotoxicity of the HIV-1
JRFL envelope. Moreover, the titer of SINrep5-JRFL im-
planted was 60 times lower than the SINrep5-EGFP input
titer, underscoring the neuropathogenic features of the
HIV-1 envelope. As our in vitro data showed that SINrep5-
JRFL is toxic to neurons, these observations indicate that
the infected neurons may have died, leaving only the SIN-
rep5-JRFL-infected cells of microglial lineage 7 days after
infection. Alternatively, the microglia and macrophages
could have internalized the HIV-1 envelope during the pro-
cess of phagocytosing the SINrep5-JRFL-infected neurons.
The observed neuronal loss and the presence of HIV-1
envelope in microglia complements an in vitro study by
Boutet et al. in which microglia infected with an HIV-1
envelope expressing SFV vector induced cell death in un-
infected bystander cells, but not in the infected microglia
(Boutet et al., 2000).
Many studies demonstrating neurotoxicity of HIV-1 en-
velope have been performed using purified recombinant
envelope protein, frequently from a non-brain-derived
HIV-1 strain (Bagetta et al., 1996; Bansal et al., 2000;
Bennett et al., 1995; Corasaniti et al., 2001), or in transgenic
animals expressing one or more HIV-1 proteins (Hanna et
al., 1998a, b, 2001; Jolicoeur et al., 1992; Toggas et al.,
1994). Given that we show that SIN infects human and
murine cell types relevant to HIV-1 pathogenesis, the use of
SIN vectors for expression of HIV-1 genes ex vivo and in
vivo offers a novel tool for elucidating mechanisms of
neuropathogenesis. Furthermore, the transient expression of
heterologous genes by SIN vectors, the minimal intrinsic
cytoxic properties of individual vectors, and the broad host
cell tropism makes these vectors appealing for pathogenesis
studies but also as therapeutic tools for acute neurological
diseases.
Material and methods
Construction of SINrep5-EGFP and SINrep5-JRFL
The SIN vector system used in this study has been
described previously (Bredenbeek et al., 1993). The con-
structs pSINrep5-EGFP and pSINrep5-JRFL were obtained
by cloning the EGFP and HIV-1 envelope genes, respec-
tively, into the multiple cloning site present in the pSINrep5
expression vector. To construct pSINrep5-EGFP, pEGFP-N1
(Clontech, Palo Alto, CA) was digested with SmaI and
HpaI, and the resulting 862-bp DNA fragment, containing
the EGFP ORF, was isolated from an agarose gel using the
Concert Rapid Gel extraction kit of Life Technologies Inc.
(Burlington, ON) and inserted into the StuI restriction site of
the pSINrep5 multiple cloning site. SINrep5-JRFL was con-
structed by inserting the envelope ORF of the brain-derived
HIV-1 strain JRFL (Li et al., 1991) into pSINrep5. The
HIV-1 JRFL envelope insert was obtained by digesting the
expression vector pCMV-JRFL (Zhang et al., 2001) with
KpnI and BamHI and subsequent isolation from an agarose
gel. The 2.5-kb fragment was inserted into the KpnI and
BamHI restriction sites of the polylinker of pSL1180 (Am-
ersham Pharmacia Biotech, Baie d’Urfe, QC). The resulting
construct pSL-JRFLenv was digested with SmaI and HpaI
to generate a 2.5-kb fragment containing the HIV-1 JRFL
envelope ORF, which was subsequently cloned into the StuI
site of the multiple cloning site of pSINrep5. For all con-
structs correct insertion of the inserts was determined by
restriction enzyme digest analysis and sequencing. All re-
striction and other enzymes were obtained from New En-
gland Biolabs (Mississauga, ON) or Life Technologies and
used according to their specifications.
Production of SINrep5-EGFP and SINrep5-JRFL virus
stocks
Constructs pSINrep5-EGFP and pSINrep5-JRFL and
helper virus construct pDH-BB (Bredenbeek et al., 1993)
were linearized with XhoI. The linearized plasmids were
used as templates for the generation of capped RNA tran-
scripts by in vitro run-off transcription using the SP6
mMESSAGE mMACHINE kit (Ambion Inc., Austin, TX).
Ten micrograms of DH-BB RNA transcript and 10 g
SINrep5-EGFP or SINrep5-JRFL RNA transcript was trans-
fected to 3–5  106 BHK-21 cells/ml in PBS by electropo-
ration according to a previously published protocol (Bre-
denbeek et al., 1993). Briefly, the cells were subjected to
two pulses at 850 V, 50 F, and 	
, using a Gene Pulser
II (Bio-Rad Laboratories Canada Ltd., Missisauga, ON).
Cells were plated in culture media and incubated at
37°C/5% CO2. The media containing recombinant SIN was
harvested 20–24 h after transfection. The SINrep5-JRFL
viral stock was concentrated by centrifugation at 120,000 g
at 4°C for 4 h and the virus pellet was dissolved in culture
media. The recombinant SIN stocks were titered on BHK
cells. For SINrep5-EGFP the titer was determined by count-
ing the number of EGFP-positive cells using fluorescent
microscopy 24 h postinfection. To determine the titer of
SINrep5-JRFL, cells were immunostained using monoclo-
nal antibody B13 directed against the HIV-1 envelope (Aba-
cioglu et al., 1994) and the number of HIV envelope-
positive cells were counted. On average 5  106 to 3  107
infectious virus particles per milliliter were obtained for
SINrep5-EGFP and 4  104 particles/ml (0.5  106 parti-
cles/ml after concentration) were obtained for SINrep5-JRFL.
Infection and transfection of neuronal and nonneuronal
cell lines
The SINrep5-EGFP virus stocks were used to infect
neuronal and nonneuronal cell lines derived from different
species including C17.2 (mouse neuroprogenitor) (Snyder
et al., 1992), NG108 (mouse neuroblastoma), LAN-2 (hu-
man cholinergic neurons, a gift from Dr. J. Rylett, Univer-
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sity of Western Ontario), and U373 (human transformed
astrocytes), seeded typically at densities of between 2.5 and
5  104 cells/cm2. The nonneuronal cell lines used were
CrFK, HeLa (human cervical carcinoma), and 293T (human
embryonic kidney epithelia). The HeLa, NG108, U373,
CrFK, and 293T cell lines were all obtained from the
ATCC. All cells were infected using serial dilutions of the
virus stock. Percentage infection efficiency of the different
cell lines was determined by counting the number of EGFP-
positive cells relative to the number of EGFP-positive cells
produced by the same amount of virus on BHK-21 cells.
The different cell lines were also used to introduce the
SINrep5-EGFP RNA by electroporation.
In addition, the level of EGFP transgene expression in
BHK-21, NG108, and U373 cells was determined by infect-
ing cells seeded in 96-well plates at 104 cells/well with
SINrep5-EGFP at a matched m.o.i., resulting in equal num-
bers of infected cells (17 and 35%, respectively) and deter-
mining the amount of EGFP fluorescence in the cells 24 h
postinfection using a fluorescent plate reader (Wallac VIC-
TOR2 1420 multilabel counter; Perkin–Elmer, Wellesley,
MA). Infection of each cell line was repeated in triplicate in
two separate experiments.
Infection of primary neuronal cultures and neural stem
cells
Primary cultures were obtained for rat embryonic striatal
neurons, mouse adult (postnatal day 21) oligodendrocytes,
mouse fetal neurons, human fetal neurons, and mixed cul-
tures of human adult oligodendrocytes, astrocytes, and mi-
croglia. All primary cultures were prepared according to
previous described protocols (Corley et al., 2001; Vecil et
al., 2000; Weiss et al., 1993) and were kindly provided by
the laboratories of Drs V.W. Yong and S. Weiss, University
of Calgary. To infect the primary cultures, 105 infectious
particles of SINrep5-EGFP were added to culture media.
The cultures were incubated at 37°C/5% CO2 for up to 2
days. Infection was determined by fluorescent microscopy
for EGFP using a standard fluorescent microscope setup
(Axioskop 2, Carl Zeiss Canada Ltd., Toronto, ON). Pri-
mary cultures were also immunostained with antibodies
directed against oligodendrocyte (MBP, Serotec, Oxford,
UK), astrocyte (GFAP, Dako, Glostrup, Denmark), and
microglial (CD14) markers to determine the identity of the
infected cells and assess the cell composition of the primary
cultures. Adult and embryonic neural stem cells were iso-
lated from mice according to previously published protocols
(Daadi and Weiss, 1999). Stem cells were infected for 1 h at
37°C/5% CO2, and infection was determined by fluorescent
microscopy for EGFP after 24 and 48 h.
Infection of organotypic hippocampal tissue slices
Organotypic rat hippocampal slices were prepared as
previously described (Stoppini et al., 1991). Slices were in
culture for 7 to 14 days before infection with SINrep5-
EGFP. Hippocampal slices were infected by adding 105
infectious virus particles per milliliter to the culture media
and by incubating for 1–5 days. The tissue slices were fixed
in PBS/4% paraformaldehyde 1, 2, 3, and 5 days after
infection and infection of the tissue slices was determined
by confocal laser scanning microscopy (Armstrong and
MacVicar, 2001) for EGFP.
Analysis of cytotoxicity of SINrep5-EGFP and SINrep5-
JRFL in vitro
NG108, LAN-2, and U373 cells were infected for 24 and
48 h with SINrep5-EGFP or SINrep5-JRFL using an m.o.i.
of 0.1, 1, and 5 for SINrep5-EGFP and 0.1 and 0.3 for
SINrep5-JRFL. As control, equal volumes of conditioned
medium, obtained from mock transfected BHK cells, were
incubated with the different cell lines (mock). After 24 and
48 h the percentage of cell death was assessed by trypan
blue exclusion and compared to the mock-infected controls.
The cytotoxicity of both recombinant viruses was tested in
triplicate in two separate experiments for each cell line. The
indirect cytotoxic effects of the recombinant SIN virus vec-
tors were tested by infecting human MDM, as well as
human primary astrocytes, with SINrep5-EGFP and SIN-
rep5-JRFL for 4 h at 37°C/5% CO2. All MDM infections
were repeated in triplicate using MDM derived from three
different donors/individuals. The astrocyte infections were
performed in duplicate. The inoculum was replaced with
AIM-V media and cells were incubated for 20 h at 37°C/5%
CO2. In addition, cell death in human MDM and primary
astrocytes was measured by Trypan blue exclusion 24 h
after the initial infection by SINrep5-EGFP, SINrep5-JRFL,
and mock infection. Subsequently, the conditioned media of
the MDM and primary astrocytes were tested for neuro-
toxicity by incubating the human LAN-2 cell line for 24
and 48 h with that conditioned AIM-V media and by
determining cell death by trypan blue exclusion. As con-
trol, conditioned media of MDM and primary astrocytes
incubated with media from mock-transfected BHK cells
were used. The cytotoxicity of conditioned media derived
from the MDM and primary astrocytes was tested in
triplicate in two separate experiments. To assess the role
of glutamate receptors in neuronal death, the neurotox-
icity of conditioned media derived from primary astro-
cytes was also determined in the presence of 30 and 100
M of the NMDA and AMPA receptor antagonists
NBQX and MK801, respectively (Sheardown et al.,
1990; Wong et al., 1986) (Sigma-Aldrich Canada Ltd.,
Oakville ON).
Stereotactic implantation of SINrep5-EGFP and SINrep5-
JRFL in the mouse striatum
The right striata of 3-week-old SCID/NOD mice were
stereotacticaly implanted with SINrep5-EGFP (3  107
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particles/ml) (n  8) and SINrep5-JRFL (0.5  106 parti-
cles/ml) (n  4), in a volume of 2 l over 5 min in
accordance with CACCA guidelines. Control mice were
implanted with media from mock-transfected BHK-21 cells
(n  3) or PBS (n  4). As no differences were observed in
behavior and inflammatory responses in the brain between
these two groups, these animals will be addressed as con-
trols for ease of discussion. The coordinates for the implant
were 3 mm posterior, 2.5 mm lateral, and 3 mm deep
relative to the bregma. Rotary behavior of the implanted
animals was analyzed at 3 and 7 days after implantation,
following intraperitoneal injection of 1 mg/kg amphetamine
(Johnston et al., 2001; Ungerstedt and Arbuthnott, 1970).
Animals were sacrificed at day 1, 3, and 7 and intracardially
perfused with saline followed by PBS/4% paraformalde-
hyde. Subsequently, the brain was removed and postfixed in
PBS/4% paraformaldehyde until histochemical analysis.
Immunohistochemistry
Fixed brain tissue was incubated for 72 h in 30% sucrose
in PBS, embedded, and frozen on dry ice in Tissue Tek
O.C.T. compound (Sakura Finetek USA, Torrance, CA).
Sections of frozen tissue measuring 10 m were cut using a
cryostat (Leica, Richmond Hill, ON). The tissue slices were
analyzed by direct fluorescent microscopy for EGFP using a
confocal microscope (Fluoview FV300, Olympus,
Markham, ON). An EGFP-specific antibody (Santa Cruz
Biotechnology Inc., Santa Cruz, CA) was also used to vi-
sualize infected cells. A monoclonal antibody B13, directed
against HIV-1 envelope (Abacioglu et al., 1994), was used
to detect HIV-1 envelope expression in animals infected
with SINrep5-JRFL. In addition, tissue sections were im-
munostained using antibodies directed against GFAP, Iba-1
(Imai et al., 1996; Ito et al., 1998), and neuronal nuclei
(NeuN) (Chemicon Int., Temecula, CA) using previously
described procedures (Power et al., 1993).
Statistical analyses
All statistical analyses were performed using Graphpad
InStat Version 3.01 (GraphPad Software, San Diego, CA)
and P values of less than 0.05 were considered significant.
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